FDA DEVICE FACTS
EVA NEXUS Ophthalmic Surgical System
D.O.R.C. Dutch Ophthalmic Research Center (International)
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The EVA NEXUS™ Ophthalmic Surgical System is indicated for both anterior segment (i.e. phacoemulsification and removal of cataracts) and posterior segment (i.e., vitreoretinal) ophthalmic surgery, including subretinal microinjection of gases or aqueous fluids. In addition, the optional laser is indicated for the following: Condition Treatment Diabetic Retinopathy
• Proliferative Diabetic Retinopathy • Panretinal Photocoagulation
• Clinically Significant Macular Edema • Focal or Grid Laser Retinal Tear and Detachments Laser Retinopathy Lattice Degeneration Retinal Photocoagulation Sub-retinal (choroidal) Neovascularization Focal Laser Retinal Vascular Occlusion
• Neovascularization secondary to Brand or Central retinal vein occlusion
• Scatter Laser Photocoagulation
• Chronic macular edema secondary to Branch or Central retinal vein occlusion
• Focal or Grid Laser Glaucoma
• Primary Open-angle • Trabeculoplasty
• Closed Angle • Iridotomy or Iridoplasty
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。